This class was created by Brainscape user Bryan Remuto. Visit their profile to learn more about the creator.

Decks in this class (48)

E2: CLINICAL SAFETY DATA MANAGEMENT
Adverse event or adverse experience,
Adverse drug reaction adr,
Unexpected adverse drug reaction
8  cards
E6: GUIDELINE FOR GOOD CLINICAL PRACTICE VOCABULARY
Adverse drug reaction adr,
Adverse event ae,
Applicable regulatory requirement s
62  cards
E6: 13 PRINCIPLES OF GCP
22,
21,
23
13  cards
E6: IRB/IEC - Responsibilities
Irb iec,
The irb iec should obtain the fol...,
312
9  cards
E6: IRB/IEC - Composition, Functions and Operations
321,
322,
323
6  cards
E6: IRB/IEC - Procedures
The IRB/IEC should establish, document in writing, and follow its procedures, which should include:
9  cards
E6: Investigator's Qualifications and Agreements
411,
412,
413
11  cards
E6: Medical Care of Trial Subjects
432,
431,
433
4  cards
E6: Communication with IRB/IEC
44 communication with irb iec441,
442,
443
3  cards
E6: Compliance with Protocol
45 compliance with protocol,
452,
453
4  cards
E6: Investigational Products
455,
456,
463
6  cards
E6: Informed Consent of Trial Subjects
48 informed consent of trial subj...,
482,
483
15  cards
E6: Records and Reports
49 records and reports490,
491,
492
10  cards
E6: Safety Reporting
411 safety reporting,
4112,
4113
3  cards
E6: Premature Termination or Suspension of a Trial
412 premature termination or susp...,
4121,
4122
5  cards
E6: Quality Management
50 quality management,
501,
502
8  cards
E6: Quality Assurance and Quality Control
51 quality assurance and quality ...,
512,
513
4  cards
E6: Contract Research Organization (CRO)
52 contract research organization...,
522,
523
4  cards
E6: Trial Management, Data Handling, and Record Keeping
Trial management data handling an...,
552,
553
12  cards
E6: Investigator Selection
56 investigator selection561,
562,
563
3  cards
E6: Notification/Submission to Regulatory Authority(ies)
510 before initiating the clinica...
1  cards
E6: Confirmation of Review by IRB/IEC
511 confirmation of review by irb...,
5112,
5113
3  cards
E6: Information on Investigational Product(s)
512 information on investigationa...,
5122
2  cards
E6: Manufacturing, Packaging, Labelling, and Coding Investigational Product(s)
513 manufacturing packaging label...,
5132,
5134
5  cards
E6: Supplying and Handling Investigational Product(s)
514 supplying and handling invest...,
5142,
5143
5  cards
E6: Safety Information
516 safety information5161,
5162,
517 adverse drug reaction reporti...
5  cards
E6: Monitoring
518 monitoring5181 purpose,
5182 selection and qualifications...,
5183 extent and nature of monitoring
3  cards
E6: Monitoring Responsibilities
5184 monitor s responsibilities,
A,
B
18  cards
E6: Monitoring Report/Plan
5186 monitoring reporta,
B,
C
6  cards
E6: Audit
519 auditif or when sponsors perf...,
Purpose,
5193 auditing procedures
3  cards
E6: Noncompliance/Premature Term or Suspension of Trial
Noncompliance5201,
Noncompliance5202,
Premature termination or suspensi...
4  cards
E6: Multicentre Trials
523 multicentre trialsfor multice...,
Multicentre trials523,
Multicentre trials523
5  cards
E6: CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S)
Clinical trial protocol and proto...,
Clinical trial protocol and proto...,
612
30  cards
E6: Investigation Brochure
7 investigation brochuretitle page,
Contents of the investigator s br...,
Contents of the investigator s br...
8  cards
E6: Essential Documents
81,
Essential documents81,
Essential documents81
7  cards
E8: GENERAL CONSIDERATIONS FOR CLINICAL STUDIES
31 considerations for the develop...,
3111 safety studiesfor the first ...,
3112 pharmacological and pharmaco...
3  cards
1572 Form
1572
1  cards
Belmont Report
Respect for persons,
Beneficence,
Justice
3  cards
Declaration of Helsenki
Declaration of helsenki,
Declaration of helsenki,
Declaration of helsenki
37  cards
Nuremberg Code
Nuremberg code1,
Nuremberg code2,
Nuremberg code3
10  cards
Pill Calculation - Compliance
Pill count method
1  cards
E8: Phase I (Most typical kind of study: Human Pharmacology)
Phase ipharmacologyobjective of s...,
Phase ipharmacologystudy examples,
3131 phase i most typical kind of...
7  cards
E 8: Phase II (Most typical kind of study: Therapeutic Exploratory)
Phase iitherapeutic exploratory,
2  cards
E8: Phase III (Most typical kind of study: Therapeutic Confirmatory)
Phase iiitherapeuticconfirmatory,
Phase iiitherapeuticconfirmatorys...
2  cards
E8: Phase IV (Variety of Studies: - Therapeutic Use)
Phase ivtherapeutic useobjective ...,
Phase ivtherapeutic useobjective ...
2  cards
E8: General Consideration for Clinical Trials
3135,
314 special considerations,
3141 studies of drug metabolites
4  cards
E9: STATISTICAL PRINCIPLES FOR CLINICAL TRIALS
212 confirmatory trial,
Exploratory,
Human pharmacology
9  cards
E11: Clinical Trials in Pediatric Population
0  cards

More about
XyZ_Res

  • Class purpose General learning

Learn faster with Brainscape on your web, iPhone, or Android device. Study Bryan Remuto's XyZ_Res flashcards now!

How studying works.

Brainscape's adaptive web mobile flashcards system will drill you on your weaknesses, using a pattern guaranteed to help you learn more in less time.

Add your own flashcards.

Either request "Edit" access from the author, or make a copy of the class to edit as your own. And you can always create a totally new class of your own too!

What's Brainscape anyway?

Brainscape is a digital flashcards platform where you can find, create, share, and study any subject on the planet.

We use an adaptive study algorithm that is proven to help you learn faster and remember longer....

Looking for something else?

Make Flashcards